| Literature DB >> 32377402 |
Joseph James Valadez1, Sima Berendes1, Jackline Odhiambo1, William Vargas1, Baburam Devkota1, Richard Lako2, Caroline Jeffery1.
Abstract
Introduction: Is achievement of Sustainable Development Goal (SDG) 16 (building peaceful societies) a precondition for achieving SDG 3 (health and well-being in all societies, including conflict-affected countries)? Do health system investments in conflict-affected countries waste resources or benefit the public's health? To answer these questions, we examine the maternal, newborn, child and reproductive health (MNCRH) service provision during protracted conflicts and economic shocks in the Republic of South Sudan between 2011 (at independence) and 2015.Entities:
Keywords: child health; health policies and all other topics; health policy; health systems evaluation; maternal health
Mesh:
Year: 2020 PMID: 32377402 PMCID: PMC7199709 DOI: 10.1136/bmjgh-2019-002093
Source DB: PubMed Journal: BMJ Glob Health ISSN: 2059-7908
Indicators used during the household surveys in South Sudan, 2011 and 2015
| Indicator | Definition | Client population* (for denominators) | Indicator source† | |
|
| ||||
| 1 | ANC 4+ | % women who received antenatal care by any health personnel ≥4 times during last pregnancy | MoC <12 months | MDG 5.5, CD2015 |
| 2 | Malaria prophylaxis | % women who received ≥2 IPTs for malaria during pregnancy | MoC <12 months | CD2015 |
| 3 | Tetanus prophylaxis | % mothers who received ≥2 tetanus toxoid injections before the birth of their youngest child or had lifetime immunity (card confirmed) | MoC <12 months | Related to CD2015 |
| 4 | Institutional delivery¶ | % women who delivered in a health facility during last pregnancy | MoC <12 months | UHC |
| 5 | PNC for mother | % women with ≥1 postnatal care visit within 6 weeks post partum with any health personnel during last pregnancy | MoC <12 months | Related to CD2015 |
|
| ||||
| 6 | Measles vaccination | % children who received ≥1 dose of measles vaccine | MoC 12–23 months | MDG 4.3, CD2015, UHC |
| 7 | DPT3 vaccination | % children who received three DPT vaccinations | MoC 12–23 months | CD2015, UHC |
| 8 | All basic vaccines | % children who received all basic vaccines (1 BCG, 4 OPV, 3 DPT, 1 measles) | MoC 12–23 months | UHC |
|
| ||||
| 9 | Vitamin A supplementation | % children aged 6 months to 5 years who received vitamin A supplementation in the past 6 months | MoC 0–59 months | Related to CD2015 |
| 10 | Malaria treatment | % children with fever who received appropriate antimalarial drugs (ACT) | MoC 0–59 months with fever in the past 2 weeks | MDG 6.8, CD2015, UHC |
| 11 | Diarrhoea treatment | % children treated with ORS | MoC 0–59 months with diarrhoea in the past 2 weeks | CD2015 |
| 12 | Pneumonia care seeking | % children with suspected pneumonia taken to an appropriate health provider | MoC 0–59 months with fast, difficult breathing in the past 2 weeks | CD2015, UHC |
|
| ||||
| 13a/13b | HIV testing, women/men | % women/men tested for HIV in the last 12 months and received their results | Women/men 15–49 years | GARPR |
|
| ||||
| 14a/14b | MTCT knowledge, women/men | % women/men who know 2+ ways in which HIV is transmitted from an infected mother to her child | Women/men 15–49 years | |
| 15a/15b | Prevention knowledge‡, women/men | % women/men who correctly identify using condoms and being faithful as ways of preventing sexual HIV transmission | Women/men 15–49 years | HIV SID 4.1 |
| 16a/16b | Misconception knowledge 1‡ (mosquito), women/men | % women/men who correctly reject the misconception that HIV can be transmitted by mosquito bites | Women/men 15–49 years | HIV SID 4.2.2 |
| 17a/17b | Misconception knowledge 2‡ (food), women/men | % women/men who correctly reject the misconception that HIV can be transmitted by sharing food with an infected person | Women/men 15–49 years | HIV SID |
| 18a/18b | Misconception knowledge 3‡ (witchcraft), women/men | % women/men who correctly reject the misconception that HIV can be transmitted by witchcraft | Women/men 15–49 years | HIV SID |
|
| ||||
| 19a | STI knowledge, women | % women who know at least two signs/symptoms of STIs in women | Women 15–49 years | Related to BSS |
| 19b | STI knowledge, men | % men who know at least two signs/symptoms of STIs in men | Men 15–49 years | Related to BSS |
|
| ||||
| 20 | Contraception among non-pregnant women (modern)§ | % women of reproductive age, currently not pregnant†, using at least one modern contraception method | Women 15–49 years | Related to UHC |
| 21 | Contraception among all married women (modern)§ | % married women of reproductive age, using at least one modern contraception method | Women 15–49 years | UHC |
| 22a/22b | Condom use women/men | % women/men who reported use of a condom the last time they had sex with a non-marital or non-cohabiting partner in the past 12 months | Women/men 15–49 years | Related to MDG 6.2 |
*MoC <12 months=mothers of children aged less than 12 months; MoC 12–23 months=mothers of children aged 12–23 months; MoC 0–59 months=mothers of children aged 0–59 months.
†For 2015, we computed this indicator with all women (pregnant and non-pregnant) in the denominator, per the UHC indicators and also MDG indicators, although the latter do not restrict contraception to modern methods, but include traditional methods.
‡We did not combine prevention and misconception knowledge indicators because national stakeholders predicted knowledge to be very low, which would have resulted in extremely low estimates for composite indicators.
§Modern methods of contraception include female and male sterilisation, oral hormonal pills, intrauterine devices, male and female condoms, injectables, implants (including Norplant), vaginal barrier methods and spermicides.
¶Institutional delivery means delivery in a hospital, or primary healthcare clinic (PHCC).
ACT, artemisinin-based combination therapy; ANC, antenatal care; BSS, Behavioral Surveillance Survey; CD2015, Countdown to 2015 for maternal, newborn and child survival; DPT, diphtheria/pertussis/tetanus; GARPR, Global AIDS Response Progress Reporting indicators (before 2012 known as UNGASS indicators); HIV SID, HIV/AIDS Survey Indicator Database; IPT, intermittent preventive treatment; MDG, Millennium Development Goal; MTCT, mother-to-child transmission of HIV; OPV, Oral Polio Vaccine; ORS, oral rehydration salts; PNC, postnatal care; STI, sexually transmitted infection; UHC, universal health coverage; UNGASS, United Nations General Assembly Special Session.
Study population characteristics (unweighted), South Sudan household survey, 2011 and 2015
| Client population | 2011 survey* | 2015 survey | ||||||||
| Sample size, n† | Mean age, years (SD) | Married, n (%) | Received any formal schooling, n (%) | Respondent's child's mean age, months (SD) | Sample size, n‡ | Mean age (SD) | Married, n (%) | Received any formal schooling, n (%) | Respondent's child's mean age, months (SD) | |
| Mothers of children aged <12 months | 1199 | 28.2 (6.6) | 1094 (91.7) | 287 | 6.1 | 1348 | 27.1 (6.7) | 1179 (87.5) | 414 | 6.1 (3.1) |
| Mothers of children aged 12–23 months | 1064 | 28.5 (7.7) | 957 | 234 | 16.8 | 1348 | 28.3 (6.9) | 1182 (87.7) | 377 | 16.9 (3.7) |
| Mothers of children aged 0–59 months | 1237 | 29.9 (7.0) | 1123 (90.8) | 274 | 27.0 | 1348 | 29.1 (7.4) | 1160 (86.1) | 350 | 29.0 |
| Mothers of children age 0–59 months with fever in the past 2 weeks | 1249 | 29.3 (6.8) | 1118 (90.8) | 230 | 25.6 | 1348 | 28.8 (7.2) | 1153 (85.5) | 351 | 23.6 |
| Mothers of children aged 0–59 months with diarrhoea in the past 2 weeks | 1235 | 29.6 (6.9) | 1122 (90.6) | 261 | 24.1 | 1348 | 28.4 (7.3) | 1177 (87.3) | 363 | 23.3 |
| Mothers of children aged 0–59 months with fast, difficult breathing in the past 2 weeks | 1235 | 29.5 (7.4) | 1112 (90.4) | 260 | 25.0 | 1348 | 28.4 (6.8) | 1170 (86.8) | 370 | 22.0 |
| Women 15–49 years | 1246 | 28.3 (8.4) | 838 (67.5) | 330 (26.5) | NA | 1348 | 28.4 (8.1) | 1038 (77.0) | 433 | NA |
| Men 15–49 years | 1245 | 32.1 (8.8) | 799 (64.8) | 607 (48.8) | NA | 1348 | 32.9 (9.0) | 1041 (77.2) | 695 | NA |
*The 2011 survey included Unity State, which we exclude here to compare the 2011 and 2015 results.
†The 2011 sample size should have been 66 counties×19 villages=1254 for all eight client populations (see online supplementary table S1), but was reduced for all of the client populations due to missing data.
‡The 2015 sample size should have been 71 counties×19 villages=1349 interviews per client population, but was actually 1348, as the records of one village were missing.
NA, not applicable; SD, Standard Deviation.
Progress in health service coverage (2011–2015) and national coverage proportions in 2015
| Indicator | 2015 vs 2011 difference in weighted coverage proportions (%) | P value* | Weighted national coverage proportions (%), 2015 | HSDP† coverage target (%) for 2015 |
|
| ||||
| ANC 4+ | 1.6 (±3.4) | 0.358 | 22.4 (±2.5) | 40 |
| Malaria prophylaxis | 8.6 (±3.9) | <0.001 | 33.1 (±2.9) | 40 |
| Tetanus prophylaxis | 3.1 (±3.1) | 0.047 | 13.7 (±2.3) | 80 |
| Institutional delivery | 10.5 (±3.4) | <0.001 | 27.0 (±2.6) | 25 |
| PNC for mother (any provider) | 1.7 (±3.6) | 0.359 | 22.8 (±2.6) | |
|
| ||||
| Measles vaccination | 11.2 (±4.2) | <0.001 | 49.7 (±2.8) | |
| DPT3 vaccination | 13.1 (±3.6) | <0.001 | 34.7 (±2.6) | 85 |
| All basic vaccines | 11.3 (±3.0) | <0.001 | 20.8 (±2.3) | 50† |
|
| ||||
| Vitamin A supplementation | −26.4 (±3.2) | <0.001 | 4.8 (±1.6) | 80 |
| Malaria treatment (ACT) | 15.8 (±3.6) | <0.001 | 31.3 (±2.8) | |
| Diarrhoea treatment (ORS) | 17.7 (±4.1) | <0.001 | 51.4 (±2.9) | 80 |
| Pneumonia care seeking | 5.9 (±4.0) | 0.004 | 66.1 (±2.8) | |
|
| ||||
| HIV testing, women | 7.3 (±2.8) | <0.001 | 17.0 (±2.2) | NA |
| HIV testing, men | 8.2 (±2.9) | <0.001 | 18.6 (±2.3) | NA |
|
| ||||
| MTCT knowledge, women | 6.0 (±2.9) | <0.001 | 17.3 (±2.4) | NA |
| MTCT knowledge, men | 6.6 (±3.4) | <0.001 | 23.1 (±2.7) | NA |
| HIV prevention knowledge, women | 0.5 (±1.9) | 0.641 | 8.9 (±1.6) | NA |
| HIV prevention knowledge, men | 1.9 (±3.0) | 0.218 | 17.6 (±2.3) | NA |
| HIV misconception knowledge 1 (mosquito), women | 7.0 (±4.0) | 0.001 | 38.5 (±2.9) | NA |
| HIV misconception knowledge 1 (mosquito), men | 6.9 (±4.0) | 0.001 | 48.8 (±2.8) | NA |
| HIV misconception knowledge 2 (food), women | 8.8 (±3.6) | <0.001 | 55.1 (±2.6) | NA |
| HIV misconception knowledge 2 (food), men | 7.1 (±3.7) | <0.001 | 64.0 (±2.6) | NA |
| HIV misconception knowledge 3 (witchcraft), women | 12.1 (±3.9) | <0.001 | 60.2 (±2.6) | NA |
| HIV misconception knowledge 3 (witchcraft), men | 6.8 (±3.7) | <0.001 | 68.1 (±2.5) | NA |
|
| ||||
| STI knowledge, women | 9.4 (±3.8) | <0.001 | 48.6 (±2.8) | NA |
| STI knowledge, men | 12.0 (±4.0) | <0.001 | 58.1 (±2.9) | NA |
|
| ||||
| Contraception (non-pregnant) | 0.6 (±2.6) | 0.653 | 7.1 (±1.9) | NA |
| Contraception (all married) | nc | 4.9 (±1.6) | 20 | |
| Condom use, women | nc | 18.0 (±9.1) | NA | |
| Condom use, men | nc | 38.2 (±6.7) | NA | |
*Results of two-sample, two-sided Z-test of proportions to test for significant change between 2011 and 2015.
†The HSDP target refers to card-confirmed vaccinations, while our indicators include mothers’ oral report of vaccinations.
ACT, artemisinin-based combination therapy; ANC, antenatal care; CI, Confidence Interval; DPT, diphtheria/pertussis/tetanus; HSDP, Health Sector Development Plan for the Republic of South Sudan; MTCT, mother-to-child transmission; NA, not applicable; nc, not computed comparative results, as explained above; ORS, oral rehydration salts; PNC, postnatal care; STI, sexually transmitted infection.
Weighted state proportions for MNCRH, HIV and STI indicators, South Sudan household survey, 2015
| Indicator* | Weighted state coverage proportions (%) and in parenthesis 95% CI (%) | ||||||||
| UN | Jonglei/GPAA | Warrap | NBeG | WBeG | Lakes | WES | CES | EES | |
|
| |||||||||
| ANC 4+ | 21.4 (±7.2) | 11.0 (±3.6) | 9.9 (±5.1) | 27.6 (±10.7) | 37.7 (±9.3) | 18.6 (±6.6) | 30.7 (±7.7) | 40.0 (±9.7) | 19.4 (±6.2) |
| Malaria prophylaxis | 36.0 (±8.9) | 29.8 (±6.3) | 24.3 (±6.4) | 43.1 (±12.3) | 36.4 (±10.9) | 33.7 (±8.2) | 36.7 (±8.2) | 42.4 (±10.1) | 22.3 (±6.4) |
| Tetanus prophylaxis | 6.7 (±4.1) | 8.8 (±4.1) | 8.0 (±5.3) | 12.0 (±8.3) | 17.6 (±9.2) | 8.9 (±4.9) | 16.6 (±6.8) | 32.4 (±10.0) | 9.7 (±5.0) |
| Institutional delivery | 13.0 (±5.7) | 14.9 (±4.9) | 14.1 (±6.0) | 25.3 (±11.0) | 42.6 (±10.9) | 26.5 (±7.5) | 37.6 (±8.0) | 55.1 (±9.4) | 21.7 (±6.2) |
| PNC for mother | 20.0 (±7.2) | 11.8 (±4.3) | 25.1 (±7.7) | 36.2 (±11.7) | 6.2 (±2.9) | 10.8 (±5.5) | 37.8 (±7.5) | 27.9 (±8.7) | 26.9 (±6.9) |
|
| |||||||||
| Measles vaccination | 46.7 (±9.0) | 56.5 (±6.4) | 27.7 (±8.3) | 26.6 (±9.3) | 48.5 (±8.8) | 49.4 (±8.5) | 55.4 (±7.7) | 73.1 (±8.7) | 51.7 (±7.8) |
| DPT3 vaccination | 25.5 (±8.0) | 23.1 (±5.8) | 21.0 (±7.4) | 19.3 (±8.1) | 51.1 (±10.0) | 23.1 (±6.9) | 42.8 (±8.0) | 70.1 (±8.3) | 39.0 (±6.8) |
| All basic vaccines | 18.8 (±7.4) | 9.6 (±4.3) | 7.6 (±4.4) | 11.3 (±5.9) | 41.1 (±9.0) | 16.4 (±6.3) | 19.0 (±7.0) | 48.6 (±9.4) | 23.9 (±6.4) |
|
| |||||||||
| Vitamin A supplementation | 5.0 (±4.6) | 4.6 (±4.1) | 0.9 (±1.1) | 2.7 (±2.6) | 9.7 (±10.1) | 3.2 (±3.2) | 12.9 (±8.0) | 3.5 (±5.1) | 8.4 (±6.6) |
| Malaria treatment | 30.9 (±8.5) | 21.7 (±5.8) | 24.8 (±6.9) | 38.4 (±11.7) | 24.1 (±8.9) | 25.8 (±7.4) | 27.2 (±7.0) | 53.4 (±10.2) | 29.1 (±7.2) |
| Diarrhoea treatment | 50.9 (±8.2) | 55.6 (±6.2) | 38.9 (±8.1) | 64.6 (±10.7) | 36.3 (±10.1) | 49.7 (±8.1) | 56.6 (±7.4) | 60.5 (±10.3) | 40.8 (±7.7) |
| Pneumonia care seeking | 57.2 (±8.1) | 64.9 (±6.1) | 54.4 (±8.7) | 59.7 (±12.4) | 52.0 (±10.8) | 72.6 (±7.1) | 81.6 (±6.1) | 82.2 (±7.8) | 61.1 (±7.7) |
|
| |||||||||
| HIV testing, women | 4.9 (±3.5) | 10.4 (±4.3) | 2.8 (±2.9) | 3.7 (±5.6) | 33.2 (±7.8) | 6.9 (±4.3) | 52.2 (±7.6) | 29.1 (±9.3) | 21.7 (±6.6) |
| HIV testing, men | 9.6 (±5.5) | 11.6 (±4.5) | 4.6 (±3.8) | 8.1 (±5.5) | 18.6 (±8.6) | 12.2 (±5.7) | 50.5 (±7.8) | 34.3 (±9.8) | 20.0 (±6.4) |
|
| |||||||||
| MTCT knowledge, women | 20.4 (±7.2) | 15.0 (±5.0) | 16.4 (±6.9) | 20.0 (±9.8) | 6.3 (±6.5) | 18.1 (±6.5) | 29.7 (±7.0) | 17.9 (±7.6) | 11.5 (±5.2) |
| MTCT knowledge, men | 31.4 (±7.2) | 21.6 (±5.7) | 24.1 (±8.2) | 19.9 (±10.4) | 18.4 (±10.0) | 23.1 (±7.2) | 30.2 (±7.1) | 21.5 (±8.5) | 20.8 (±6.4) |
| Prevention knowledge, women | 13.6 (±6.8) | 10.5 (±4.5) | 0.3 (±0.6) | 4.5 (±6.1) | 3.8 (±4.0) | 2.1 (±2.5) | 29.8 (±6.9) | 11.3 (±4.3) | 6.6 (±4.1) |
| Prevention knowledge, men | 23.0 (±7.6) | 18.1 (±5.4) | 7.9 (±5.6) | 12.1 (±8.8) | 11.1 (±7.5) | 18.0 (±6.9) | 39.2 (±7.4) | 23.2 (±7.2) | 8.6 (±4.2) |
| Misconception knowledge 1 (mosquito), women | 44.3 (±8.4) | 31.7 (±6.4) | 25.8 (±8.3) | 47.7 (±11.9) | 35.4 (±7.4) | 21.3 (±7.2) | 39.3 (±7.9) | 60.1 (±9.7) | 39.0 (±7.4) |
| Misconception knowledge 1 (mosquito), men | 60.0 (±7.5) | 41.0 (±6.7) | 37.8 (±9.3) | 40.8 (±12.0) | 43.7 (±7.2) | 34.0 (±8.4) | 43.4 (±8.3) | 82.2 (±6.1) | 48.2 (±7.4) |
| Misconception knowledge 2 (food), women | 45.0 (±8.5) | 40.7 (±6.4) | 25.1 (±8.0) | 55.6 (±11.4) | 70.7 (±9.0) | 49.1 (±8.6) | 74.9 (±6.8) | 84.4 (±5.6) | 64.1 (±6.4) |
| Misconception knowledge 2 (food), men | 58.1 (±8.3) | 51.5 (±6.7) | 51.2 (±8.6) | 58.1 (±11.8) | 65.4 (±9.5) | 57.2 (±8.4) | 81.5 (±5.9) | 91.3 (±4.7) | 63.8 (±6.5) |
| Misconception knowledge 3 (witchcraft), women | 47.0 (±8.7) | 51.3 (±6.1) | 50.4 (±8.8) | 73.1 (±9.5) | 73.2 (±10.0) | 54.9 (±8.7) | 42.5 (±5.8) | 86.0 (±6.6) | 62.0 (±6.6) |
| Misconception knowledge 3 (witchcraft), men | 63.0 (±7.4) | 56.2 (±6.2) | 67.9 (±8.6) | 84.9 (±7.9) | 81.3 (±9.3) | 62.8 (±8.2) | 49.6 (±6.1) | 87.6 (±6.5) | 64.1 (±6.6) |
|
| |||||||||
| STI knowledge, women | 31.7 (±8.0) | 45.4 (±5.4) | 45.7 (±7.7) | 49.4 (±10.9) | 38.4 (±11.2) | 45.2 (±8.2) | 58.8 (±7.5) | 68.9 (±9.5) | 40.7 (±6.8) |
| STI knowledge, men | 37.8 (±8.3) | 60.4 (±6.5) | 63.3 (±7.5) | 62.9 (±9.4) | 46.8 (±11.9) | 53.3 (±7.7) | 69.2 (±7.5) | 65.9 (±9.9) | 48.5 (±8.0) |
|
| |||||||||
| Contraception among non-pregnant women | 4.3 (±3.5) | 0.4 (±0.6) | 1.8 (±2.8) | 5.5 (±6.0) | 3.0 (±5.0) | 3.3 (±3.9) | 26.4 (±8.4) | 16.7 (±9.9) | 6.0 (±4.5) |
| Contraception among all married women | 2.5 (±2.5) | 0.4 (±0.5) | 1.6 (±2.4) | 5.0 (±5.5) | 2.3 (±4.5) | 2.7 (±3.1) | 16.3 (±7.1) | 12.4 (±7.9) | 4.4 (±3.8) |
We do not report state-level results for the condom use indicators, because sample sizes for this indicator were too small due to a combination of the low number of persons responding affirmatively to the related questions for the construction of the denominator (having engaged in extramarital sex) and numerator (having used a condom at last extramarital sex) and missing values.
*For indicator definitions see table 1.
ACT, Artemisinin-based combination therapy; ANC, antenatal care; CES, Central Equatoria; DPT, diphtheria/pertussis/ tetanus; EES, Eastern Equatoria; GPAA, Greater Pibor Administrative Area; int. ind, international indicator (including both married and unmarried women, excluding pregnant women); Jong, Jonglei; know, knowledge; m, men; MTCT, Mother to Child Transmission; NBeG, Northern Bahr el Ghazal; ORS, oral rehydration salts; PNC, postnatalcare; prev, prevention; STI, Sexually Transmitted Infection; UN, Upper Nile; w, women; Warr, Warrap; WBeG, Western Bahr el Ghazal; WES, Western Equatoria.